Identification of Novel Biomarkers and Candidate Drug in Ovarian Cancer
This paper investigates the expression of the CREB1 gene in ovarian cancer (OV) by deeply excavating the gene information in the multiple databases and the mechanism thereof. In short, we found that the expression of the CREB1 gene in ovarian cancer tissue was significantly higher than that of norma...
Main Authors: | Chia-Jung Li, Li-Te Lin, Pei-Yi Chu, An-Jen Chiang, Hsiao-Wen Tsai, Yi-Han Chiu, Mei-Shu Huang, Zhi-Hong Wen, Kuan-Hao Tsui |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-04-01
|
Series: | Journal of Personalized Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4426/11/4/316 |
Similar Items
-
A Combined Long Noncoding RNA Signature as a Candidate Prognostic Biomarker for Ovarian Cancer
by: Hui Li, et al.
Published: (2021-05-01) -
Identification of four hub genes as promising biomarkers to evaluate the prognosis of ovarian cancer in silico
by: Jingxuan Chen, et al.
Published: (2020-06-01) -
Identification of Potential Bisphenol A (BPA) Exposure Biomarkers in Ovarian Cancer
by: Aeman Zahra, et al.
Published: (2021-05-01) -
Integrative analysis of key candidate genes and signaling pathways in ovarian cancer by bioinformatics
by: Cuicui Dong, et al.
Published: (2021-07-01) -
KLF7: a new candidate biomarker and therapeutic target for high-grade serous ovarian cancer
by: Marta De Donato, et al.
Published: (2020-11-01)